Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Puma Biotechnology (NQ: PBYI)
8.340 USD  +0.290 (+3.60%)
Streaming Delayed Price  /  Updated: 2:12 PM EST, Jan 28, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 723,865
Open 8.170
Bid (Size) 8.320 (2)
Ask (Size) 8.340 (4)
Prev. Close 8.050
Today's Range 7.970 - 8.420
52wk Range 6.260 - 43.90
Shares Outstanding 37,811,611
Dividend Yield N/A
Performance
YTD
-1.07%
-1.07%
1 Month
-0.83%
-0.83%
3 Month
+10.32%
+10.32%
6 Month
-10.61%
-10.61%
1 Year
-69.11%
-69.11%
Top News
More News
Puma Biotechnology Releases Slides to be Presented at the J.P. Morgan Healthcare Conference
On Jan. 13, 2020, Puma Biotechnology released the slides that CEO Alan Auerbach will present at the J.P. Morgan Healthcare Conf. on Jan. 15. Read More
from Business Wire News Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
On January 9, 2020, Puma Biotechnology reported inducement awards granted in December 2019 under Nasdaq Listing Rule 5635(c)(4). Read More
from Business Wire News Releases
More News
Read More
Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference
from Business Wire News Releases
We Did The Math VBK Can Go To $220
category ETFs
from ETF Channel
Interesting PBYI Put And Call Options For March 6th
category Stocks
from Market News Video
First Week of PBYI September 18th Options Trading
category Stocks
from Market News Video
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
from Business Wire News Releases
Noteworthy Friday Option Activity: ALNY, EHTH, PBYI
category Stocks
from Market News Video
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS
from Business Wire News Releases
plasmaMATCH Trial Shows Neratinib Activity in ERBB2 (HER2) Mutant Metastatic Breast Cancer
from Business Wire News Releases
February 28th Options Now Available For Puma Biotechnology (PBYI)
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.